BioRhex was built to operate differently.

Every compound is synthesized in a GMP-compliant, US-based facility. Every batch is tested by independent third-party laboratories using HPLC and mass spectrometry verification, with sterility testing conducted to research-grade standards.

Every order ships with a Certificate of Analysis — not as a marketing feature, but as a baseline requirement.

≥99% purity is not a claim. It is a documented, verifiable threshold we hold every batch to before it ships.
This is not a higher bar than other suppliers. This is the bar that should have existed from the start.

What Every BioRhex Compound Goes Through

No compound ships without meeting every requirement below.

USA Manufacturing

Synthesized in a domestic, GMP-compliant facility. No offshore sourcing. No unverifiable supply chain.

GMP-Compliant Production

Every compound is produced under Good Manufacturing Practice standards, ensuring consistency across every batch.

HPLC Purity Verification

High-performance liquid chromatography testing confirms compound identity and purity against established reference standards.

Mass Spectrometry Confirmation

Mass spectrometry analysis verifies molecular weight and compound identity, providing a second independent layer of purity confirmation.

Sterility Testing

Each batch undergoes sterility testing to research-grade standards before release.

≥99% Purity Threshold

BioRhex maintains a minimum purity threshold of ≥99% across all compounds. Batches that do not meet this standard are not released.

High-Demand Research Compounds

Fast, Reliable US Shipping

All BioRhex compounds ship from within the United States.

Orders are processed promptly with tracking provided on every shipment. Research timelines should not be delayed by supply logistics.